Shingles Vaccination 2021-22  for ease of administration the majority of Zostavax® has previously been given to eligible patients at the same time as their flu vaccine and is given throughout the year to those who did not receive it during the flu season period for whatever reason. 

A 7 day period must be left between COVID-19 and the shingles vaccine being administered and therefore the shingles vaccine will now be administered separately to Flu and Covid vaccine.  

Patients with severe immunosuppression and are aged between 70-79 years of age, are eligible for the vaccine and are recommended to receive the non-live shingles vaccine Shingrix® as they are unable to receive the live vaccine Zostavax®.  Appointments can be booked via reception.


Click to view a selection of Patient Information Flu Leaflets

Seasonal influenza and COVID-19 viruses have the potential to add substantially to the winter pressures usually faced by the HSC, particularly if infection waves from both viruses coincide.  Influenza vaccination is therefore an important priority this coming autumn to reduce associated with influenza infections, and to reduce hospitalisations during a time when the HSC may also be managing winter outbreaks of COVID-19. 

This year the annual seasonal influenza immunisation programme aims to provide direct protection to those who are at higher risk of influenza associated morbidity and mortality.  Groups eligible for influenza vaccination are based on the advice of the Joint Committee on Vaccination and Immunisation (JCVI) and include older people, pregnant women, children, those with certain underlying medical conditions and frontline health and social care workers.  

Health and Social CareThis site is brought to you by My Surgery Website